Application 219859
- Type
- ANDA
- Sponsor
- GRAVITI PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LOSARTAN POTASSIUM | LOSARTAN POTASSIUM | TABLET;ORAL | 25MG | No | No |
| 002 | LOSARTAN POTASSIUM | LOSARTAN POTASSIUM | TABLET;ORAL | 50MG | No | No |
| 003 | LOSARTAN POTASSIUM | LOSARTAN POTASSIUM | TABLET;ORAL | 100MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A219859-001 | LOSARTAN POTASSIUM | LOSARTAN POTASSIUM | 25MG | TABLET / ORAL | AB | 2025-09-19 | |
| A219859-002 | LOSARTAN POTASSIUM | LOSARTAN POTASSIUM | 50MG | TABLET / ORAL | AB | 2025-09-19 | |
| A219859-003 | LOSARTAN POTASSIUM | LOSARTAN POTASSIUM | 100MG | TABLET / ORAL | AB | 2025-09-19 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A219859-001 | AB |
| A219859-002 | AB |
| A219859-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A219859-001 | LOSARTAN POTASSIUM | 25MG | TABLET / ORAL | AB | 2025-09-19 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A219859-002 | LOSARTAN POTASSIUM | 50MG | TABLET / ORAL | AB | 2025-09-19 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A219859-003 | LOSARTAN POTASSIUM | 100MG | TABLET / ORAL | AB | 2025-09-19 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A219859-001 | LOSARTAN POTASSIUM | 25MG | TABLET / ORAL | AB | 2025-09-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A219859-002 | LOSARTAN POTASSIUM | 50MG | TABLET / ORAL | AB | 2025-09-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A219859-003 | LOSARTAN POTASSIUM | 100MG | TABLET / ORAL | AB | 2025-09-19 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A219859-001 | LOSARTAN POTASSIUM | 25MG | TABLET / ORAL | AB | 2025-09-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A219859-002 | LOSARTAN POTASSIUM | 50MG | TABLET / ORAL | AB | 2025-09-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A219859-003 | LOSARTAN POTASSIUM | 100MG | TABLET / ORAL | AB | 2025-09-19 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A219859-001 | LOSARTAN POTASSIUM | 25MG | TABLET / ORAL | AB | 2025-09-19 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A219859-002 | LOSARTAN POTASSIUM | 50MG | TABLET / ORAL | AB | 2025-09-19 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A219859-003 | LOSARTAN POTASSIUM | 100MG | TABLET / ORAL | AB | 2025-09-19 | 31067a03dcf5… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219859-001 | LOSARTAN POTASSIUM | 25MG | TABLET / ORAL | AB | 2025-09-19 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219859-002 | LOSARTAN POTASSIUM | 50MG | TABLET / ORAL | AB | 2025-09-19 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219859-003 | LOSARTAN POTASSIUM | 100MG | TABLET / ORAL | AB | 2025-09-19 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A219859-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A219859-002 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A219859-003 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A219859-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A219859-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A219859-003 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A219859-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A219859-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A219859-003 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A219859-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A219859-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A219859-003 | AB | 1 | 31067a03dcf5… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219859-001 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219859-002 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219859-003 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Losartan potassium | LOSARTAN POTASSIUM | Novadoz Pharmaceuticals LLC | 5edb843a-66ed-4950-9ed0-393e6a5d7c99 | 2026-02-06 | Boxed warning, Warnings, Adverse reactions | Losartan potassium LOSARTAN POTASSIUM |
| LOSARTAN POTASSIUM 25 mg | LOSARTAN POTASSIUM | Strides Pharma Science Limited | a8817f22-8478-49b9-8354-ab27ca222c6b | 2026-01-21 | Boxed warning, Warnings, Adverse reactions | LOSARTAN POTASSIUM |
| COZAAR | LOSARTAN POTASSIUM | Organon LLC | 9949448f-c3b9-44ee-94ed-c1aca8c90f39 | 2026-01-20 | Boxed warning, Warnings, Adverse reactions | LOSARTAN POTASSIUM |
| Losartan Potassium | LOSARTAN POTASSIUM | Lupin Pharmaceuticals, Inc. | e5886220-43b7-46e1-9034-5242ba245bd1 | 2026-01-13 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
| Losartan Potassium | LOSARTAN POTASSIUM | Zydus Lifesciences Limited | 9ccd6823-e813-472c-99cd-c6ef25e74bed | 2026-01-12 | Losartan Potassium LOSARTAN POTASSIUM | |
| Losartan Potassium | LOSARTAN POTASSIUM | Quallent Pharmaceuticals Health LLC | 1a9e1ffd-edf1-4e35-a7f5-ca351c507d7f | 2026-01-12 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
| Losortan Potassium | LOSARTAN POTASSIUM | AvPAK | a6cd0b5f-2bd6-bed9-e053-2995a90a3191 | 2026-01-08 | Boxed warning, Warnings, Adverse reactions | LOSARTAN POTASSIUM |
| LOSARTAN POTASSIUM 50 mg | LOSARTAN POTASSIUM | Northwind Health Company, LLC | c29d999d-adc9-6c66-e053-2995a90a1fc3 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | LOSARTAN POTASSIUM |
| Losartan Potassium | LOSARTAN POTASSIUM | Northwind Health Company, LLC | d9ced981-d791-6600-e053-2995a90ace3b | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
| Losartan Potassium | LOSARTAN POTASSIUM | Northwind Health Company, LLC | d9de3627-9aa2-65c8-e053-2995a90ab5ec | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
| Losartan Potassium | LOSARTAN POTASSIUM | Northwind Health Company, LLC | d9df33c8-4ea7-5d1c-e053-2a95a90aecf7 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
| Losartan Potassium | LOSARTAN POTASSIUM | Northwind Health Company, LLC | d9dfae69-9ce7-0c6b-e053-2a95a90aace8 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
| Losartan Potassium | LOSARTAN POTASSIUM | QPharma, Inc. | 0c9f3e8c-eafb-4be4-aca5-1d5aa3d7d738 | 2025-12-19 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
| Losartan Potassium | LOSARTAN POTASSIUM | QPharma, Inc. | c80b36c2-fa22-e7a9-e053-2a95a90ae21e | 2025-12-19 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
| Losartan Potassium | LOSARTAN POTASSIUM | QPharma, Inc. | c80b3a28-ef15-5902-e053-2995a90a06d7 | 2025-12-19 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
| Losartan Potassium | LOSARTAN POTASSIUM | QPharma, Inc. | 2a7513c4-b73b-46fe-ba86-6e58658cdbc7 | 2025-12-15 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
| Losartan Potassium | LOSARTAN POTASSIUM | QPharma, Inc. | 16a6a582-eb4d-41bc-9d49-fc1d4117b29a | 2025-12-15 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
| Losartan Potassium | LOSARTAN POTASSIUM | AiPing Pharmaceutical, Inc. | 1ae817aa-5221-4387-a457-306785140741 | 2025-12-12 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
| Losartan Potassium | LOSARTAN | Granules Pharmaceuticals Inc. | ca012edc-923d-4ada-a261-db82b71b3c4f | 2025-12-04 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium |
| Losartan Potassium | LOSARTAN POTASSIUM | A-S Medication Solutions | 67ffab1a-9e80-48dd-a6c6-1b586161fe50 | 2025-11-26 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.